MAXONA Pharmaceuticals' Phase 2 clinical trial IND application for MAX-001 cleared by US FDA

FDA grants priority review to Genentech's Gazyva for primary membranous nephropathy

AstraZeneca signs global licence deal with Dizal for lung cancer drug Zegfrovy

Summit Therapeutics sells Phase III antibiotic asset ridinilazole to Biossil

European Commission approves Erbitux combination for first-line BRAF V600E-mutant mCRC

US FDA accepts BioMarin's sNDA for full approval of VOXZOGO (vosoritide) for children with achondroplasia

Eisai reports new data showing etalanetug reduces Alzheimer's Disease tau tangle‑specific biomarker

FDA approves Sanofi's subcutaneous Sarclisa Escena as first anticancer therapy delivered via on-body injector

Accord BioPharma's second pegfilgrastim biosimilar to NEULASTA approved by US FDA

BiBBInstruments signs first European distribution deal for EndoDrill GI with Palex Spain

Vector Science and Therapeutics names Darryl Drake Jr. president of Valor athlete and performance division

Invictus Pharmacy and Mullan Pharmaceutical partner to expand patient access to Ganirelix Acetate Injection

Vanda Pharmaceuticals' investigational therapy for Charcot-Marie-Tooth disease type 2S granted FDA Rare Pediatric Disease Designation

Ascletis submits two IND applications to US FDA for obesity treatments

AbbVie's TEPKINLY (epcoritamab) combination approved in Europe to treat relapsed or refractory follicular lymphoma